- Design, Synthesis, and Biological Evaluation of Novel Transrepression-Selective Liver X Receptor (LXR) Ligands with 5,11-Dihydro-5-methyl-11-methylene-6H-dibenz[b,e]azepin-6-one Skeleton
[作者:AOYAMA ATSUSHI; ENDOUMEDA KAORI; KISHIDA KENJI; OHGANE KENJI; NOGUCHIYACHIDE TOMOMI; AOYAMA HIROSHI; ISHIKAWA MINORU; MIYACHI HIROYUKI; MAKISHIMA MAKOTO; HASHIMOTO YUICHI,期刊:Journal of Medicinal Chemistry, 页码:7360-7377 , 文章类型: Article,,卷期:2012年55-17]
- To obtain novel transrepression-selective liver X receptor (LXR) ligands, we adopted a strategy of reducing the transactivational agonistic activity of the 5,11-dihydro-5-methyl-11-methylene-6H-dibenz[b,e]azepin-6-one de...
- Design, Synthesis, and Evaluation of pH-Dependent Hydrolyzable Emetine Analogues as Treatment for Prostate Cancer
[作者:AKINBOYE EMMANUEL S; ROSEN MARC D; DENMEADE SAMUEL R; KWABIADDO BERNARD; BAKARE OLADAPO,期刊:Journal of Medicinal Chemistry, 页码:7450-7459 , 文章类型: Article,,卷期:2012年55-17]
- The N-2' position of the natural product emetine has been derivatized to thiourea, urea, sulfonamide, dithiocarbamate, carbamate, and pH responsive hydrolyzable amide analogues. In vitro studies of these analogues in PC3...
- Solubility-Driven Optimization of Phosphodiesterase-4 Inhibitors Leading to a Clinical Candidate
[作者:PRESS NEIL J; TAYLOR ROGER J; FULLERTON JOSEPH D; TRANTER PAMELA; MCCARTHY CLIVE; KELLER THOMAS H; ARNOLD NICOLA; BEER DAVID; BROWN LYNDON; CHEUNG ROBERT; CHRISTIE JULIE; DENHOLM ALASTAIR; HABERTHUER SANDRA; HATTO JULIA D I; KEENAN MARK; MERCER MARK K; OAKMAN HELEN; SAHRI HELENE; TUFFNELL ANDREW R; TWEED MORRIS; TYLER JOHN W; WAGNER TRIXIE; FOZARD JOHN R; TRIFILIEFF ALEXANDRE,期刊:Journal of Medicinal Chemistry, 页码:7472-7479 , 文章类型: Article,,卷期:2012年55-17]
- The solubility-driven optimization of a series of 1,7-napthyridine phosphodiesterase-4 inhibitors is described. Directed structural changes resulted in increased aqueous solubility, enabling superior pharmacokinetic prop...
- Rational Design of a Low Molecular Weight, Stable, Potent, and Long-Lasting GPR103 Aza-beta(3)-pseudopeptide Agonist
[作者:NEVEU CINDY; LEFRANC BENJAMIN; TASSEAU OLIVIER; DOREGO JEANCLAUDE; BOURMAUD ADELE; CHAN PHILIPPE; BAUCHAT PATRICK; LE MAREC OLIVIER; CHUQUET JULIEN; GUILHAUDIS LAURE; BOUTIN JEAN A; SEGALASMILAZZO ISABELLE; COSTENTIN JEAN; VAUDRY HUBERT; BAUDYFOCH MICHELE; VAUDRY DAVID; LEPRINCE JEROME,期刊:Journal of Medicinal Chemistry, 页码:7516-7524 , 文章类型: Article,,卷期:2012年55-17]
- 26RFa, a novel RFamide neuropeptide, is the endogenous ligand of the former orphan receptor GPR103. Intracerebroventricular injection of 26RFa and its C-terminal heptapeptide, 26RFa((20-26)), stimulates food intake in ro...
- Discovery of a Novel Noniminosugar Acid alpha Glucosidase Chaperone Series
[作者:XIAO JINGBO; WESTBROEK WENDY; MOTABAR OMID; LEA WENDY A; HU XIN; VELAYATI ARASH; ZHENG WEI; SOUTHALL NOEL; GUSTAFSON ANN MARIE; GOLDIN EHUD; SIDRANSKY ELLEN; LIU KE; SIMEONOV ANTON; TAMARGO RAFAEL J; RIBES ANTONIA; MATALONGA LESLIE; FERRER MARC; MARUGAN JUAN J,期刊:Journal of Medicinal Chemistry, 页码:7546-7559 , 文章类型: Article,,卷期:2012年55-17]
- Pompe disease is an autosomal recessive lysosomal storage disorder (LSD) caused by deficiency of the lysosomal enzyme acid a-glucosidase (GAA). Many disease-causing mutated GAA retain enzymatic activity but are not trans...
|